MedTrace Logo

Efficacy and Safety of Perlane-L in the Correction of Midface Volume Deficit

NCT01565915 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 221

Last updated 2013-08-21

No results posted yet for this study

Summary

The purpose of this study is to determine if Perlane-L is safe in increasing cheek volume.

Conditions

  • Facial Volume

Interventions

DEVICE

Perlane-L

Perlane-L Injection in the midface

OTHER

Non-treatment

Non-treatment Arm

Sponsors & Collaborators

  • Medicis Global Service Corporation

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01565915 on ClinicalTrials.gov